Novel Drug Delivery Methods and Approaches for the Treatment of Retinal Diseases

Medicine and Dentistry

• Retina Disease 100%
• Intravitreal Administration 66%
• Health Care Cost 33%
• Clinical Trial 33%
• Diabetes 33%
• Microparticle 33%
• Gene Therapy 33%
• Systemic Therapy 33%
• Implant 33%
• Topical Treatment 33%
• Sustained Drug Release 33%
• Intraocular Drug Administration 33%
• Prodrug 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Intravitreal Administration 66%
• Sustained Release 33%
• Prodrug 33%
• Ocular Drug 33%
• Clinical Trial 33%
• Implant 33%
• Microparticle 33%